For specialists

The effectiveness of the use of eye drops with Ketorolac in the complex treatment of anterior uveitis
Published in the journal «Ophthalmology. Eastern Europe» Vol 7 № 2’2017
Medical correction of acute pain syndrome in the complex treatment of injuries of the musculoskeletal system
Published in the journal «Trauma» Vol 18 № 2 ’2017
A new complex of metabolic substances and vitamins in the treatment of eye burns and their consequences
Published in a journal «Ophthalmology. Eastern Europe» Vol 7 № 2 ’2017
Determination of the optimal scheme of administration of Cocarnite to rats with diabetic polyneuropathy using the tensoalgometric method
Published in the journal «Problems of regulation of physiological functions» № 2(23) ’2017
Effectiveness of pain control in inflammatory joint diseases using the injectable form of meloxicam
Published in the journal "Neurology and Neurosurgery. Eastern Europe" Vol. 7 No. 2 '2017
Modern approaches to the choice of antianemic therapy in adolescent girls with juvenile abnormal uterine bleeding
Published in the magazine «Word of Health» № 2’2017
Effect of L-carnitine on the lipid profile of patients with coronary artery disease
Published in thematic issue «Cardiology, Rheumatology, Cardiac Surgery» № 1 (50) ’2017
Correction of secondary carnitine deficiency in chronic hemodialysis patients: focus on levocarnitine
Published in the journal «Kidneys» № 1 (19) ’2017
Influence of Medotilin on the functional state of patients after acute cerebrovascular accident
Published in the journal «Emergency Medicine» № 1 (80) ’2017
Clinical experience of ketoprofen in the treatment of acute and chronic pain
Published in the journal “Trauma” Vol. 18 No. 1 '2017

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design